A Guide to Laboratory Biosafety Levels

The American Biological Safety Association (ABSA) sets the standard for biosafety levels and laboratory requirements in the United States. To mitigate the risk of infection and contamination from pathogenic microorganisms, the ABSA has developed four distinct biosafety levels that, when properly implemented, should contain harmful biological agents and prevent contamination. What Biosafety Level Should My…

Read more

After SLAS2018: The Next Generation of Scientists

SLAS is one of those events that always leaves us reflective and inspired on our return trip home. This year, our chief scientist, Ben Tjoa, and I attended the event San Diego. We met amazing scientists, had meaningful conversations, and heard from world leaders. SLAS2018 set a new attendance record — over 6,600 attendees from…

Read more
blood types

Is Your Blood Type in High Demand?

Unless you’re part of the medical industry, you don’t spend much time thinking about your blood type. After all, your blood type doesn’t impact your everyday life. As long as your blood is circulating and you feel healthy, you’re good to go. But blood type is a huge issue in the world of blood donation,…

Read more

SLAS2018 Restaurant Guide: San Diego

SLAS2018 is back in San Diego at the San Diego Convention Center February 3–7, 2018. If you’re heading to SLAS for the first time, I recommend checking out their website to learn all that the conference has to offer. Outside of amazing presenters and exhibitors, you will find a variety of networking opportunities and educational…

Read more

Anti-SIRPα Antibodies: A Promising Avenue for Immunotherapy

Conventional cancer therapies such as chemotherapy and radiation have a significant downfall: while targeting cancerous tumors, they also damage healthy cells which can lead to undesirable patient side-effects. Despite high expectations at the onset, treatments using monoclonal antibodies have historically faced limitations. While attempting to discover why monoclonal antibodies were not performing as expected, researchers…

Read more